NGT3 is a unique venture capital fund and partnership, with European, American and Israeli partners, who share the vision of investment in early-stage technology-based start-up companies with social agenda. NGT3 brings new opportunities while remaining rooted in Nazareth, the largest Arab city in Israel’s Galilee. We start and fund early-stage companies, primarily in innovative medical devices and life sciences, and encourage Arab and Jewish entrepreneurship. NGT3 companies operate within the framework of an Israeli government-licensed technological incubator.


NGT3 is an early-stage VC, focused on medical technologies. We’ve been working with MSCOMMS for several years now,  getting support for us and for our portfolio companies.

mscomms are exceptionally creative in finding the story, the angle, and the right media channel to publish. Both Iris and her staff are professional, service-oriented, very pleasant, and doers – pushing every opportunity and creating opportunities, to get maximal exposure

Zohar Gendler


An interview with NGT3 management and employees

Paragate is preparing for the clinical trial of fluid pumping technology

Bylined Article by the CTO & VP business development, NGT3

Bylined Article by NGT3's CEO about raising capital for Israeli medical startups - Japan VS China

The real-life sciences – who arrived to the NGT3 event?

Bylined article on the integration of Israeli Arabs into the Israeli hi-tech field

An interview at the "Unicorn" column of Geektime, a leading tech site, with the management of NGT3, a unique VC, and incubator in the life science industry

An interview with Virility Medical (NGT3 portfolio startup company) founder